Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation
- 30 April 2011
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 23 (2), 178-183
- https://doi.org/10.1016/j.coi.2011.01.001
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Sin1-mTORC2 Suppresses rag and il7r Gene Expression through Akt2 in B CellsMolecular Cell, 2010
- The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancyProceedings of the National Academy of Sciences of the United States of America, 2010
- Foxo1 regulates marginal zone B‐cell developmentEuropean Journal of Immunology, 2010
- Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapyOncogene, 2010
- Suppression of Phosphatidylinositol 3,4,5-Trisphosphate Production Is a Key Determinant of B Cell AnergyImmunity, 2009
- PI3 Kinase Signals BCR-Dependent Mature B Cell SurvivalCell, 2009
- Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiationNature Immunology, 2008
- Foxo1 directly regulates the transcription of recombination-activating genes during B cell developmentNature Immunology, 2008
- Tenets of PTEN Tumor SuppressionCell, 2008
- BAFF controls B cell metabolic fitness through a PKCβ- and Akt-dependent mechanismThe Journal of Experimental Medicine, 2006